Press Releases :: Ligand Pharmaceuticals Incorporated (LGND)

Press Releases

Ligand’s Partner Melinta Therapeutics Announces U.S. FDA Approval of Baxdela™ (Delafloxacin) for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

June 20, 2017

Ligand Enters into Worldwide OmniAb® Platform License Agreement with Surface Oncology

June 1, 2017

Ligand Announces Aziyo Biologics Acquires Commercial Products from Partner CorMatrix

May 31, 2017

Ligand Enters Into Worldwide OmniAb® Platform License Agreement With xCella Biosciences

May 30, 2017

Ligand to Participate in Two Upcoming Investor Conferences

May 22, 2017

Ligand Reports First Quarter 2017 Financial Results

May 9, 2017

Ligand to Report First Quarter 2017 Results on May 9th

April 13, 2017

Ligand Enters Commercial License and Supply Agreements with Marinus Pharmaceuticals for Captisol-Enabled Ganaxolone

April 5, 2017

Ligand Announces Licensing Partner Janssen Has Filed an IND for an Antibody Discovered Using the OmniAb® Technology

March 28, 2017

Ligand to Participate in Upcoming Investor Conference

March 9, 2017